Transcenta Holding Limited (HKG:6628)
Hong Kong · Delayed Price · Currency is HKD 1.470
-0.030 (-2.00%)
Jun 18, 2026, 10:09 AM HKT
Transcenta Holding Market Cap
Transcenta Holding has a market cap or net worth of 639.97 million as of June 17, 2026. Its market cap has increased by 11.84% in one year.
Market Cap
639.97M
Enterprise Value
764.74M
Revenue
8.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.47
Market Cap Chart
Since April 27, 2022, Transcenta Holding's market cap has decreased from 2.75B to 639.97M, a decrease of -76.76%. That is a compound annual growth rate of -29.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 639.97M | -32.90% |
| Dec 31, 2025 | 953.77M | 274.36% |
| Dec 31, 2024 | 254.77M | -82.96% |
| Dec 29, 2023 | 1.50B | 14.88% |
| Dec 30, 2022 | 1.30B | -52.74% |
| Apr 27, 2022 | 2.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cutia Therapeutics | 1.12B |
| Cloudbreak Pharma | 1.02B |
| Sunho Biologics | 970.43M |
| Wuhan YZY Biopharma | 775.40M |
| 3D Medicines | 723.01M |
| Brii Biosciences | 707.37M |
| JW (Cayman) Therapeutics Co. | 645.37M |
| Shanghai Bio-heart Biological Technology | 591.50M |